… rationale for therapeutic targeting of GM-CSF in COVID-19-associated hyperinflammation. …
and host defence, we discuss potential risks associated with inhibition of GM-CSF in the …

… The association between G6PD deficiency and COVID 19 has not yet been reported despite
… Interleukin-6 (IL-6) has been proposed to play an essential role in COVID-19 associated …

… Sarilumab was associated with faster recovery in a subset of … of COVID-19 response to
anti-inflammatory therapies.15 Indeed… conditions, was recently associated to clinical improvement …

… available anti-inflammatory therapeutic options at the time of the COVID-19 outbreak. Low-…
might be needed to suppress COVID-19-related hyperinflammation. 29 patients received high-…

… in COVID-19 related hyperinflammation. It also emphasized on the efficacy of both synthetic
and natural therapeutic drugs for immunomodulation in the COVID-19 … that early blockade of …

… injury and inflammation in patients with severe COVID-19 (29, 30… with COVID-19 exhibit
elevated gene expression related to … -6R), exerts therapeutic effects by blocking the binding of IL-…

… , termed COVID-19, is multifactorial and associated with both … these therapeutics according
to the stage of COVID-19 … an association of CD147 blockade by meplazumab, with an …

… severe COVID-19 infection as well as therapeutic strategies … with anakinra or other IL-1
blocking agents [Citation36] Serum … patients with COVID-19-associated hyperinflammation found …

… COVID-19 severity appears to be associated with the degree … with COVID-19 may benefit
from therapeutic complement … over-activated in COVID-19, blocking these pathways may …

… a hyperinflammatory vasculopathy associated with COVID-19, … therapies for abrogating lung
injury in COVID-19. There are >… the IL-1R antagonist anakinra in blocking the activity of IL-1β …